IRIS Accounts Production v24.3.2.46 10882896 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108828962023-07-31108828962024-07-31108828962023-08-012024-07-31108828962022-07-31108828962022-08-012023-07-31108828962023-07-3110882896ns15:EnglandWales2023-08-012024-07-3110882896ns14:PoundSterling2023-08-012024-07-3110882896ns10:Director12023-08-012024-07-3110882896ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3110882896ns10:SmallEntities2023-08-012024-07-3110882896ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3110882896ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3110882896ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3110882896ns10:FullAccounts2023-08-012024-07-3110882896ns10:OrdinaryShareClass12023-08-012024-07-3110882896ns5:CurrentFinancialInstruments2024-07-3110882896ns5:CurrentFinancialInstruments2023-07-3110882896ns5:Non-currentFinancialInstruments2024-07-3110882896ns5:Non-currentFinancialInstruments2023-07-3110882896ns5:ShareCapital2024-07-3110882896ns5:ShareCapital2023-07-3110882896ns5:RetainedEarningsAccumulatedLosses2024-07-3110882896ns5:RetainedEarningsAccumulatedLosses2023-07-3110882896ns10:RegisteredOffice2023-08-012024-07-3110882896ns5:FurnitureFittings2023-07-3110882896ns5:MotorVehicles2023-07-3110882896ns5:ComputerEquipment2023-07-3110882896ns5:FurnitureFittings2023-08-012024-07-3110882896ns5:MotorVehicles2023-08-012024-07-3110882896ns5:ComputerEquipment2023-08-012024-07-3110882896ns5:FurnitureFittings2024-07-3110882896ns5:MotorVehicles2024-07-3110882896ns5:ComputerEquipment2024-07-3110882896ns5:FurnitureFittings2023-07-3110882896ns5:MotorVehicles2023-07-3110882896ns5:ComputerEquipment2023-07-3110882896ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3110882896ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3110882896ns10:OrdinaryShareClass12024-07-31108828961ns10:Director12023-07-31108828961ns10:Director12022-07-31108828961ns10:Director12023-08-012024-07-31108828961ns10:Director12022-08-012023-07-31108828961ns10:Director12024-07-31108828961ns10:Director12023-07-31
REGISTERED NUMBER: 10882896 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st July 2024

for

Patemka Medical Limited

Patemka Medical Limited (Registered number: 10882896)






Contents of the Financial Statements
for the Year Ended 31st July 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Patemka Medical Limited (Registered number: 10882896)

Balance Sheet
31st July 2024

31.7.24 31.7.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 128,649 2,591

CURRENT ASSETS
Debtors 5 1,013 -
Cash at bank 228,469 163,234
229,482 163,234
CREDITORS
Amounts falling due within one year 6 39,896 15,688
NET CURRENT ASSETS 189,586 147,546
TOTAL ASSETS LESS CURRENT
LIABILITIES

318,235

150,137

CREDITORS
Amounts falling due after more than one year 7 (96,047 ) -

PROVISIONS FOR LIABILITIES (4,042 ) (397 )
NET ASSETS 218,146 149,740

CAPITAL AND RESERVES
Called up share capital 8 5 5
Retained earnings 218,141 149,735
SHAREHOLDERS' FUNDS 218,146 149,740

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Patemka Medical Limited (Registered number: 10882896)

Balance Sheet - continued
31st July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10th April 2025 and were signed on its behalf by:





Mrs U C Uzoka - Director


Patemka Medical Limited (Registered number: 10882896)

Notes to the Financial Statements
for the Year Ended 31st July 2024

1. COMPANY INFORMATION

Patemka Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10882896

Registered office: The Lexicon
10-12 Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its
estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost
Computer Equipment - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Patemka Medical Limited (Registered number: 10882896)

Notes to the Financial Statements - continued
for the Year Ended 31st July 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1st August 2023 5,195 - 2,314 7,509
Additions - 130,447 873 131,320
At 31st July 2024 5,195 130,447 3,187 138,829
DEPRECIATION
At 1st August 2023 3,351 - 1,567 4,918
Charge for year 682 4,348 232 5,262
At 31st July 2024 4,033 4,348 1,799 10,180
NET BOOK VALUE
At 31st July 2024 1,162 126,099 1,388 128,649
At 31st July 2023 1,844 - 747 2,591

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Other debtors 200 -
PAYE Control 813 -
1,013 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Other loans - (200 )
Hire purchase contracts 14,485 -
PAYE Control 1 (813 )
Tax 23,283 15,065
Directors' current accounts 3 296
Accrued expenses 2,124 1,340
39,896 15,688

Patemka Medical Limited (Registered number: 10882896)

Notes to the Financial Statements - continued
for the Year Ended 31st July 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.7.24 31.7.23
£    £   
Hire purchase contracts 96,047 -

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
5 Ordinary 1 5 5

5 Ordinary shares each of £1 were allotted, called up and fully paid at par.

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st July 2024 and 31st July 2023:

31.7.24 31.7.23
£    £   
Mrs U C Uzoka
Balance outstanding at start of year (296 ) (844 )
Amounts advanced 29,105 31,856
Amounts repaid (28,812 ) (31,308 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3 ) (296 )

The loan is payable on demand and no interest was charged during the year.

10. ULTIMATE CONTROLLING PARTY

The controlling party is Dr K C Uzoka.